Skip to Content

UK Edition. Click here for US version.

HYDRALAZINE TABLETS 50MG

Active substance(s): HYDRALAZINE HYDROCHLORIDE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Hydralazine
#50 mg
Tablets

Film-Coated

mg

REVISED ARTWORK FOR MHRA APPROVAL
VERSION: 5 (MYLAN)
DRAFT ISSUE: 3
REASON FOR CHANGE: Change to braille & cutter
SUPPLIER ISSUE DATE: 20.9.2016

Film-Coated Tablets Oral use
Each film-coated tablet contains: 50 mg hydralazine hydrochloride.
Dosage: Oral use. Read the package leaflet before use.
Keep out of the sight and reach of children.
Do not store above 25°C. Store in the original package in order to
protect from light.
PL 4569/0051 LL0508AF 901940 A0030a/5
MA Holder: Mylan, Potters Bar,
POM Hertfordshire, EN6 1TL, U.K.

DIMENSIONS 52 x 101mm
BARCODE 5055382300304
PHARMA CODE TBC
ALMUS CODE A0030a/5
SUPPLIER CODE LL0508AF
SUPPLIER CODE 901940

Almus ® is a registered trademark

Almus ® is a registered trademark

PL 4569/0051 LL0508AF 901940 A0030a/5
MA Holder: Mylan, Potters Bar,
POM Hertfordshire, EN6 1TL, U.K.

mg

56

56

Film-Coated Tablets Oral use
Each film-coated tablet contains: 50 mg hydralazine hydrochloride.
Dosage: Oral use. Read the package leaflet before use.
Keep out of the sight and reach of children.
Do not store above 25°C. Store in the original package in order to
protect from light.

Hydralazine
#50 mg
Tablets

Hydralazine Tablets 50

Hydralazine Tablets 50
Film-Coated

Hydralazine
#50 mg
Tablets

5 055382 300304

Hydralazine
#50 mg
Tablets

This leaflet was last revised in 08/2016.

Client:

Almus UK

Project:

10564 / UK
Hydralazine Tablets
50mg x 56

Item(s):

Colours used:

BLACK

PMS
349

PMS
142

PMS
218

Label Leaflet

Checked by: Paul Adams

KEYLINE
This scale measures 100mm when artwork is 100%
0
10
20
30

Queries regarding this artwork,
please contact: Steve Hobbs or
Paul Adams

BRAILLE

Date: 20.9.2016
40

50

60

70

80

90

100

pmdc design llp
Lower Test Studios
Sheardley Lane, Droxford
Hampshire SO32 3QY
+44 (0)1489 878780
www.pmdc.co.uk

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide